Krystal Biotech Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $1.33B
Liabilities Breakdown FY2025
Total Liabilities: $114.2M
Asset Breakdown
Total Assets: $1.33B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $496.3M | 37.2% |
| Accounts Receivable | $127.4M | 9.6% |
| Inventory | $40.5M | 3.0% |
| Property, Plant & Equipment | $150.8M | 11.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $518.8M | 38.9% |
Liabilities Breakdown
Total Liabilities: $114.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.2M | 2.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $111.0M | 97.2% |